Gentamicin-Loaded Polysaccharide Membranes for Prevention and Treatment of Post-operative Wound Infections in the Skeletal System

Autor: Monika Brzychczy-Włoch, Krzysztof Pietryga, Wojciech Chrzanowski, Elżbieta Pamuła, Małgorzata Krok-Borkowicz, Łucja Rumian, Dominika Kulig, Urszula Cibor
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Staphylococcus aureus
Alginates
Pharmaceutical Science
chemistry.chemical_element
02 engineering and technology
Calcium
Polysaccharide
03 medical and health sciences
chemistry.chemical_compound
Pharmacokinetics
Glucuronic Acid
Polysaccharides
Materials Testing
medicine
Humans
Pharmacology (medical)
Post operative
Pharmacology
chemistry.chemical_classification
Drug Carriers
Hexuronic Acids
Organic Chemistry
Polysaccharides
Bacterial

Membranes
Artificial

Osteomyelitis
021001 nanoscience & nanotechnology
Antimicrobial
Gellan gum
Anti-Bacterial Agents
Drug Liberation
030104 developmental biology
Membrane
Cross-Linking Reagents
chemistry
Biochemistry
Wound Infection
Molecular Medicine
Gentamicin
Collagen
Gentamicins
0210 nano-technology
Biotechnology
Nuclear chemistry
medicine.drug
Popis: To develop polysaccharide-based membranes that allow controlled and localized delivery of gentamicin for the treatment of post-operative bone infections. Membranes made of gellan gum (GUM), sodium alginate (ALG), GUM and ALG crosslinked with calcium ions (GUM + Ca and ALG + Ca, respectively) as well as reference collagen (COL) were produced by freeze-drying. Mechanical properties, drug release, antimicrobial activity and cytocompatibility of the membranes were assessed. The most appropriate handling and mechanical properties (Young’s modulus, E = 92 ± 4 MPa and breaking force, F MAX = 2.6 ± 0.1 N) had GUM + Ca membrane. In contrast, COL membrane showed F MAX = 0.14 ± 0.02 N, E = 1.0 ± 0.3 MPa and was deemed to be unsuitable for antibiotic delivery. The pharmacokinetic data demonstrated a uniform and sustainable delivery of gentamicin from GUM + Ca (44.4 ± 1.3% within 3 weeks), while for COL, ALG and ALG + Ca membranes the most of the drug was released within 24 h (55.3 ± 1.9%, 52.5 ± 1.5% and 37.5 ± 1.8%, respectively). Antimicrobial activity against S. aureus and S. epidermidis was confirmed for all the membranes. GUM + Ca and COL membranes supported osteoblasts growth, whereas on ALG and ALG + Ca membranes cell growth was reduced. GUM + Ca membrane holds promise for effective treatment of bone infections thanks to favorable pharmacokinetics, bactericidal activity, cytocompatibility and good mechanical properties.
Databáze: OpenAIRE